Literature DB >> 10529240

Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin.

P M Rudd1, T S Mattu, S Masure, T Bratt, P E Van den Steen, M R Wormald, B Küster, D J Harvey, N Borregaard, J Van Damme, R A Dwek, G Opdenakker.   

Abstract

Gelatinase B is a matrix metalloproteinase (MMP-9) involved in tissue remodeling, development, cancer, and inflammation. Neutrophils produce three major forms of (pro)gelatinase B: 92 kDa monomers, homodimers, and complexes of gelatinase B covalently bound to neutrophil gelatinase B-associated lipocalin (NGAL). In contrast to the case for other proteinases, little information about the glycosylation of any natural human MMP is available. Here, both gelatinase B and NGAL were purified from human peripheral blood neutrophils, and the entire contents of the released N- and O-glycan pools were analyzed simultaneously using recently developed high-performance liquid chromatography-based technology. The results are discussed within the context of the domain structure of gelatinase B and a molecular model of NGAL based on data from this study and the three-dimensional nuclear magnetic resonance (NMR) structure of the protein. More than 95% of the N-linked glycans attached to both gelatinase B and NGAL were partially sialylated, core-fucosylated biantennary structures with and without outer arm fucose. The O-linked glycans, which were estimated to comprise approximately 85% of the total sugars on gelatinase B, mainly consisted of type 2 cores with Galbeta1,4GlcNAc (lactosamine) extensions, with or without sialic acid or outer arm fucose. This paper also contains the first report of O-linked glycans attached to NGAL. Although both proteins were isolated from neutrophils and contained O-linked glycans mainly with type 2 cores, the glycans attached to individual serine/threonine residue(s) in NGAL were significantly smaller than those on gelatinase B. In contrast to NGAL, gelatinase B contains a region rich in Ser, Thr, and Pro typical of O-glycosylated mucin-like domains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529240     DOI: 10.1021/bi991162e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

Review 1.  New hyphenated methodologies in high-sensitivity glycoprotein analysis.

Authors:  Milos V Novotny; Yehia Mechref
Journal:  J Sep Sci       Date:  2005-10       Impact factor: 3.645

2.  Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.

Authors:  Alla L Zozulya; Emily Reinke; Dana C Baiu; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

3.  Staphylococcal superantigen-like protein 5 inhibits matrix metalloproteinase 9 from human neutrophils.

Authors:  Saotomo Itoh; Eri Hamada; Go Kamoshida; Kana Takeshita; Teruaki Oku; Tsutomu Tsuji
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

4.  Expression profiles of matrix metalloproteinase 9 in teleost fish provide evidence for its active role in initiation and resolution of inflammation.

Authors:  Magdalena Chadzinska; Pawel Baginski; Elzbieta Kolaczkowska; Huub F J Savelkoul; B M Lidy Verburg-van Kemenade
Journal:  Immunology       Date:  2008-06-14       Impact factor: 7.397

5.  Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB.

Authors:  De-xiu Bu; Anne-Louise Hemdahl; Anders Gabrielsen; Jonas Fuxe; Chaoyong Zhu; Per Eriksson; Zhong-qun Yan
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 6.  Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.

Authors:  Yu Wang
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

7.  Lipocalin 2 is required for BCR-ABL-induced tumorigenesis.

Authors:  X Leng; H Lin; T Ding; Y Wang; Y Wu; S Klumpp; T Sun; Y Zhou; P Monaco; J Belmont; A Aderem; S Akira; R Strong; R Arlinghaus
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

8.  Mutational tuning of galectin-3 specificity and biological function.

Authors:  Emma Salomonsson; Michael C Carlsson; Veronica Osla; Ruth Hendus-Altenburger; Barbro Kahl-Knutson; Christopher T Oberg; Anders Sundin; Rickard Nilsson; Eva Nordberg-Karlsson; Ulf J Nilsson; Anna Karlsson; James M Rini; Hakon Leffler
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

9.  Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1.

Authors:  Christian Ries; Thomas Pitsch; Reinhard Mentele; Stefan Zahler; Virginia Egea; Hideaki Nagase; Marianne Jochum
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

10.  Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach.

Authors:  Danmei Xu; Naoko Suenaga; Mariola J Edelmann; Rafael Fridman; Ruth J Muschel; Benedikt M Kessler
Journal:  Mol Cell Proteomics       Date:  2008-07-02       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.